You are here: vision-research.eu » News
Over the years, new scientific discoveries have led to softer and more comfortable contact lenses. And now, research bringing together chemistry, biology and microelectronics is resulting in contact lenses that are straight out of science fiction.
The Children’s Eye Foundation of AAPOS unveiled the world’s first interactive children’s book to help screen for color vision deficiency (CVD), commonly known as color blindness. The foundation has posted a free digital version of THE CURIOUS EYE at thecuriouseye.org and published a first-run, hardcover book for its member pediatric ophthalmologists.
There are millions of people who face the loss of their eyesight from degenerative eye diseases. The genetic disorder retinitis pigmentosa alone affects 1 in 4,000 people worldwide.
Nature authors say a reproducibility checklist is a step in the right direction, but more needs to be done.
Commissioner Gabriel appointed two new members to the European Commission’s Group of Chief Scientific Advisors (GCSA) for the next three years.
A minimally invasive retinal reattachment procedure that can be done in an ophthalmologist's office leads to better long-term integrity and structure of the retina's photoreceptors—cells that allow us to see—compared with more invasive operating room procedures, according to new research
Oxford Finance has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals. Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the company’s marketing of its two approved ophthalmic products.
Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.
The importance of knowledge creation and research for our well-being and the prosperity of our society and economies cannot be overstated. The ability to formulate questions and to seek answers to understand the world around us is a distinguishing feature of being human.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
A joint research effort carried out by MIPT scientists and Harvard researchers has yielded retinal cells that can integrate into the retina.
Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021 ARVO annual meeting
Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties.
Publishers are redoubling their commitment to transparency and reproducibility — but they can’t bring about change alone.
Last year, the COVID-19 pandemic upended the conference experience for researchers around the globe as scientific societies canceled in-person meetings and scrambled to hold virtual events in their place—with varying success.
vision-research.eu is kindly supported by ROCHE
Home | Contact | Sitemap | Data protection declaration | Imprint | © 2021 European Vision Institute EEIG, Belgium | info@vision-research.eu